Less Invasive vs Usual Surgery for Mitral Valve Leaks
Part of Heart & circulation clinical trials.
This trial compares a less invasive catheter procedure to the standard surgical operation to treat “secondary” leaking of the mitral valve. It may help people with significant valve leak decide which approach works better for reducing symptoms and heart strain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (not a child).
- Your mitral valve leakage is considered significant (based on echo measurements like EROA or regurgitant volume).
- Your leak is serious (typically grade 3 or 4 on ultrasound).
- An echocardiogram suggests a specific “secondary” pattern of leakage without major structural damage to the valve parts.
- Your heart ultrasound and anatomy suggest you could safely have either the catheter procedure (needs TEE) or standard mitral valve repair/replacement surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a catheter-based procedure to repair a leaking mitral valve in people who are in severe heart shock and need medication support. The goal is to reduce the valve leak and see if it helps patients stabilize and recover.
This trial tests an early, minimally invasive procedure to fix a leaky mitral valve using a catheter (a thin tube) after a heart attack. The goal is to see if fixing the valve early can help patients recover better and avoid more serious heart problems.
This study tests a new device that replaces a leaking mitral valve without open-heart surgery. It may help people who have severe mitral valve leakage but cannot safely have standard surgery or some other less invasive valve repairs.
This trial tests a new device called the Capstan system to fix a leaky mitral valve (mitral regurgitation) without open-heart surgery. It may help people whose valve leak is moderate to severe and still have symptoms despite medicines.
This trial studies a minimally invasive device meant to fix a badly leaking mitral valve (mitral regurgitation) without open-heart surgery. It may be an option if you’re considered too high-risk for standard surgery and your heart anatomy fits the device.
This trial tests a device placed during open heart surgery that tightens the leaking mitral valve to reduce blood flowing backward. It may help people whose valve leak is caused by heart muscle weakness and who are already having another heart surgery.
Hear when a new Severe Mitral Valve Regurgitation (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.